Sweden: Almost six times as many suspected side effects reported for AstraZeneca’s vaccine compared to Pfizer and Moderna

The Swedish Medical Products Agency has received almost six times as many reports of suspected side effects for AstraZeneca’s vaccine, compared with the other two EU-approved vaccines Pfizer/Biontech and Moderna, in relation to the number of people vaccinated.   More...

France: 12 cases of thromboembolic disorders following Astrazeneca coronavirus vaccine, 4 deaths

“As part of our enhanced surveillance of thromboembolic disorders, 3 new cases of thrombosis of the large veins of atypical locations associated with thrombocytopenia and/or coagulation disorders were analyzed during the weekly monitoring committee of the ANSM with the network French CRPVs (12 cases in total since the start of vaccination, including 4 deaths).  More...

Canada: NACI recommends that AstraZeneca coronavirus vaccine should not be used in adults under 55 years of age

NACI recommends that AstraZeneca COVID-19 vaccine should not be used in adults under 55 years of age at this time while the safety signal of Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT) following vaccination with AstraZeneca COVID-19 vaccine is investigated further.  More...